Evaluation of Safety and efficacy of hydrogen peroxide 35% topical solution, in Comparision to cryotherapy in on treatment of patients with senile lentigo referring to Shohada-e-Tajrish and Loghman-e-Hakim hospital in 1397-98.

Evaluation of Safety and efficacy of hydrogen peroxide 35% topical solution, in Comparision with cryotherapy in on treatment of patients with senile lentigo

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190519043632N1

Enrollment

Registered

2019-10-02

Start date

2019-07-21

Completion date

Unknown

Last updated

2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

senile lentigo.

Interventions

Intervention 1: Intervention group 1: Apply 35% hydrogen proxide topically with a cotton swab on the lentigo surface and allow the medication to remain in the area for 15 to 20 minutes to dry. Be. Int

Eligibility

Sex/Gender

All

Age

16 Years to No maximum

Inclusion criteria

Inclusion criteria: People with Fitzpatrick skin type 1-4 People without a history of drug allergy Age over 16 years No pregnancy or lactation Failure to receive other treatments to eliminate lentigo in the last 6 weeks (such as cryotherapy or imiquimod ointment) No Vitiligo

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Effectiveness of the drug. Timepoint: One week, three weeks and three months. Method of measurement: Physical examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFahimeh Salehi najaf abadi

Shahid Beheshti University of Medical Sciences

fahime.salehi@sbmu.ac.ir+98 21 4430 0796

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026